Scott Bizily

CIK: 0001920738

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (48.3%)

Position reduction

Option Exercises (M)13 (44.8%)

Derivative conversions

Awards (A)2 (6.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FDMT

4D Molecular Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

FDMT
4D Molecular Therapeutics, Inc.
Oct 16, 2026
Sale(S)
Direct
1.6K shares at avg. $12.84$21K
FDMT
4D Molecular Therapeutics, Inc.
Oct 16, 2026
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Sep 16, 2026
Sale(S)
Direct
1.6K shares at avg. $13.65$22K
FDMT
4D Molecular Therapeutics, Inc.
Sep 16, 2026
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Sep 1, 2026
Exercise(M)
Direct
584 shares at avg. $6.49$4K
FDMT
4D Molecular Therapeutics, Inc.
Sep 1, 2026
Sale(S)
Direct
584 shares at avg. $14.00$8K
FDMT
4D Molecular Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
1.6K shares at avg. $12.20$20K
FDMT
4D Molecular Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Aug 13, 2026
Sale(S)
Direct
1.6K shares at avg. $12.00$20K
FDMT
4D Molecular Therapeutics, Inc.
Aug 13, 2026
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Jun 30, 2026
Exercise(M)
Direct
814 shares at avg. $4.14$3K
FDMT
4D Molecular Therapeutics, Inc.
Jun 30, 2026
Exercise(M)
Direct
5.8K shares at avg. $6.49$37K
FDMT
4D Molecular Therapeutics, Inc.
Jun 30, 2026
Sale(S)
Direct
6.6K shares at avg. $14.00$92K
FDMT
4D Molecular Therapeutics, Inc.
Jun 23, 2026
Exercise(M)
Direct
9.8K shares at avg. $4.14$41K
FDMT
4D Molecular Therapeutics, Inc.
Jun 23, 2026
Sale(S)
Direct
9.8K shares at avg. $12.00$118K
FDMT
4D Molecular Therapeutics, Inc.
Mar 25, 2026
Award(A)
Stock Option (Right to Buy)
Direct
217K shares-
FDMT
4D Molecular Therapeutics, Inc.
Dec 16, 2025
Sale(S)
Direct
1.6K shares at avg. $10.90$18K
FDMT
4D Molecular Therapeutics, Inc.
Dec 16, 2025
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Nov 17, 2025
Sale(S)
Direct
1.6K shares at avg. $10.59$17K
FDMT
4D Molecular Therapeutics, Inc.
Nov 17, 2025
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Oct 24, 2025
Sale(S)
Direct
2.7K shares at avg. $12.00$32K
FDMT
4D Molecular Therapeutics, Inc.
Oct 24, 2025
Exercise(M)
Direct
1.1K shares at avg. $6.49$7K
FDMT
4D Molecular Therapeutics, Inc.
Oct 16, 2025
Exercise(M)
Direct
1.6K shares at avg. $4.14$7K
FDMT
4D Molecular Therapeutics, Inc.
Oct 16, 2025
Sale(S)
Direct
1.6K shares at avg. $10.17$17K
FDMT
4D Molecular Therapeutics, Inc.
Oct 9, 2025
Sale(S)
Direct
2.4K shares at avg. $10.00$24K

		Type	Shares	Price		Ownership
Oct 16, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$12.84	$20,993	Direct
Oct 16, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Sep 16, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$13.65	$22,318	Direct
Sep 16, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Sep 1, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	584	$6.49	$3,790	Direct
Sep 1, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	584	$14.00	$8,176	Direct
Aug 17, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$12.20	$19,947	Direct
Aug 17, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Aug 13, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$12.00	$19,620	Direct
Aug 13, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Jun 30, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	814	$4.14	$3,370	Direct
Jun 30, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	5,752	$6.49	$37,330	Direct
Jun 30, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	6,566	$14.00	$91,924	Direct
Jun 23, 2026	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	9,810	$4.14	$40,613	Direct
Jun 23, 2026	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	9,810	$12.00	$117,720	Direct
Mar 25, 2026	FDMT 4D Molecular Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	217,000	-	-	Direct
Dec 16, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$10.90	$17,822	Direct
Dec 16, 2025	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Nov 17, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$10.59	$17,315	Direct
Nov 17, 2025	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Oct 24, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	2,678	$12.00	$32,136	Direct
Oct 24, 2025	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,084	$6.49	$7,035	Direct
Oct 16, 2025	FDMT 4D Molecular Therapeutics, Inc.	Exercise(M)	1,635	$4.14	$6,769	Direct
Oct 16, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	1,635	$10.17	$16,628	Direct
Oct 9, 2025	FDMT 4D Molecular Therapeutics, Inc.	Sale(S)	2,408	$10.00	$24,080	Direct

1-25 of 29 transactions

About Bizily Scott

Bizily Scott (SEC CIK 0001920738) files insider reports with the SEC as Chief Legal Officer of 4D Molecular Therapeutics, Inc. (FDMT).

Signal8 holds 15 ownership filings by Bizily Scott, all Form 4s, filed between Sep 18, 2024 and Oct 20, 2026. Those filings report 29 transactions, from Sep 16, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bizily Scott's filings is in EMERYVILLE, CA.

Recent filings by Bizily Scott

Oct 16, 2026: Open-market sale of FDMT shares (Form 4, code S).
Oct 16, 2026: Option exercise of FDMT shares (Form 4, code M).
Sep 16, 2026: Open-market sale of FDMT shares (Form 4, code S).
Sep 16, 2026: Option exercise of FDMT shares (Form 4, code M).
Sep 1, 2026: Option exercise of FDMT shares (Form 4, code M).

Other insiders filing for 4D Molecular Therapeutics, Inc. (FDMT)

How to read Form 4 transaction codes